GNRH1 and cancer: Thus, the objective of this in vitro and in vivo study is to explore the efficacy of drug-loaded microporous PDMS implantable devices for the targeted and localized delivery of LHRH-conjugated cancer drugs (paclitaxel and prodigiosin).